- PB-Basics of Infection Control
- PB-Can Implicit Bias Affect the Optometric Exam?
- PB-Focus On Vision & Health Promotion For I.D. Athletes
- PB-Health Promotion, Disease Prevention, and Patient Education in an Optometric Practice - An Interprofessional Approach
- PB-Improving Patient Communication: What Does Culture Have to Do with It?
- PB-Infection Control: Implementation in a Clinical Practice
- PB-Marijuana and Driving: Your Retina and Brain
- PB-Population Health The Changing Healthcare System and Why Optometry Needs To Know
- PB-The Opioid Epidemic and Drug Diversion
- PB-The Perils of Physician Bias: What It Means and What We Need to Do About It
PB-AI and Optometry: How Autonomous Technology is Changing the Way Diabetic Retinopathy and Macular Edema are Diagnosed
Description:
In April 2018, after a rigorous preregistered clinical trial that was published in the journal Nature Digital Medicine, the U.S. Food and Drug Administration (FDA) de novo authorized IDx-DR® the first autonomous AI system. IDx-DR diagnoses (DR) and macular edema in adults who have diabetes and identifies those who need to be referred to eye care. Two years later in November 2020, EyeArt® was 510k cleared by the FDA to market a similar device. Based on claims data across all insured, only 15.3% of diabetic patients are receiving annual eye exams. To tackle this gap in care, healthcare providers are implementing point-of-care tests utilizing autonomous AI technology to complete these diabetic retinal exams outside traditional eyecare settings. This continuing education will not only reveal how AI technology is changing the way DR and macular edema are identified, but it will also help optometrists prepare for this rapidly evolving healthcare delivery model.
Course Code:
AOA223-PB
Speaker(s):
Dana Weitzman, O.D.
dena.weitzman@gmail.com
Credits:
1
AOA Expiration Date:
3/3/2025
Constant presence: Alliance builds reputation for patient safety advocacy
Founded five years ago, the Health Care Alliance for Patient Safety (HCAPS) is making good on its mission to advocate for patient safety and protect the fundamental doctor-patient relationship. The alliance’s advocacy will be recognized with the AOA’s Apollo Award during a ceremony at the 2023 Optometry’s Meeting® June 21-24.
What defines the value of care we provide?
Health and vision plans have not adapted and grown with the care we deliver but hold back optometry’s momentum.
How to speak the universal language of care
How to create a bilingual and culturally sensitive practice, why it matters to patients and how it can set you apart from the competition.